Magic mushroom compound performs as well as antidepressant in small study
Psilocybin, the active compound in magic mushrooms, may be at least as effective as a leading antidepressant medication in a therapeutic setting.
Direction of needle penetration in brain affects drug uptake, finds new study
The direction at which drug-delivering needles enter the brain affects how well medicine permeates, a new Imperial study on sheep brains has found.
Citizen scientists show placebo effect may explain benefits of microdosing
The psychological benefits linked with taking regular, small doses of psychedelic drugs are likely the result of users’ expectations, a study suggests
How mouse brains reorganise old memories when new ones are laid down
Oxford and Imperial researchers have mapped how the structure of existing memories is reorganised as new experiences are committed to memory in mice.
COVID-19 patient survey highlights prevalence of PTSD symptoms
More than one-third of COVID-19 patients put on a ventilator experience symptoms of post-traumatic stress disorder (PTSD).
Precise mapping shows how brain injuries inflict long-term damage
Researchers have shown how forces acting on the brain during traumatic injury are linked to damage seen years after the initial trauma.
3
Non-invasive brain stimulation helps to ease tremors
UK researchers have used electrical pulses to help suppress the tremors typically found in conditions such as Parkinson’s disease.
Newly described condition causes loss of vertigo and imbalance in TBI patients
A condition that causes loss of vertigo perception and imbalance has been diagnosed in traumatic brain injury patients for the first time.
Medical cannabis eases seizures in childhood epilepsy
Medicinal cannabis could offer patients significant relief from intractable epilepsy, but cost and access barriers remain, a review has found.
Imperial graduate launches app to help early diagnosis of dementia
A startup founded by an Imperial graduate has launched the first app to contribute to early diagnosis of dementia through artificial intelligence.
1
